DINOL and B-cell non-Hodgkin lymphoma: Consistent with our previous finding that Dino is a haplo-insufficient tumor suppressor in Eμ-myc driven B cell lymphoma [17], Dino−/− mice had nearly a two-fold increased incidence of B cell lymphoma (Figure S1b), although this trend did not reach statistical significance in this small cohort.